glp-1 obesity drug news today oct 2025 Drugmakers are racing to find the next Wegovy. These trials are ones to watch Could the price of GLP-1
Description
Educate patients to report fever or sore throat promptly
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Renal Outcomes Sixteen studies, including one meta-analysis, reported at least one renal outcome
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
The states with the lowest spending, North Dakota and Wyoming, dont provide Medicaid coverage for any of the obesity-indicated GLP-1s
10.1097/MCO.0b013e328302f414 82 Mauvais-JarvisF.CleggD
